JULY 12, 2019
Biophytis Announces Filing of Amendment to Registration Statement for Global Offering. Read the Press Release
JULY 8, 2019
Biophytis Announces the Launch of its Public Offering on Nasdaq. Read the Press Release
June 28, 2019
Biophytis Announces Results of 2019 Annual General Meeting of Shareholders. Read the Press Release
June 26, 2019
Biophytis Announces it Presented One Oral and One Poster Presentation at the MaculART meeting in Paris, France. Read the press release
June 12, 2019
Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon). Read the Press Release
June 07, 2019
Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer. Read the Press Release
May 22, 2019
Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States. Read the Press Release
May 22, 2019
Biophytis announces the resumption of the listing of its stock on May 23, 2019, at the opening of the markets. Read the press release
May 22, 2019
Biophytis announces the publication of its 2018 Reference Document. Read the press release
May 22, 2019
Biophytis announces suspension of trading until distribution of a press release. Read the Press Release